Today: 23 June 2026

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR shares rose 2.5% to $26.70 in premarket trading Tuesday after a 6.8% jump the prior session, nearing the top of their 52-week range. The company reported Q4 revenue of $398.3 million and adjusted EPS of $0.32, beating estimates, but net income fell to $7.8 million due to impairment and restructuring charges. Management is scheduled to meet investors at conferences in Houston and Las Vegas.
24 February 2026
··
Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics shares rose 6.3% to $52.68 Monday ahead of CEO Marino Garcia’s scheduled fireside chat at TD Cowen’s health care conference on March 3. Volume reached about 944,000 shares. Investors are watching for updates on the company’s autoimmune pipeline and trial timelines. The event will be webcast and include one-on-one investor meetings.
24 February 2026
··
Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy shares fell 1.6% to $157.80 in premarket trading Tuesday after an 8.6% surge the previous session. Director Jeffrey Immelt disclosed gifting 4,000 shares in a late Monday SEC filing. Tariff uncertainty and Nvidia’s results this week are influencing AI-linked stock moves. Bloom’s 2026 revenue forecast stands at up to $3.3 billion, with a reported backlog of about $20 billion.
24 February 2026
··
Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
·
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
24 February 2026
··
Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America shares were little changed in premarket trading Tuesday after closing down 3.75% amid a broad selloff in bank stocks. The KBW Regional Banking Index dropped 4.26% Monday as Treasury yields swung and investors weighed tariff headlines. JPMorgan, Wells Fargo, and Morgan Stanley each fell about 4%. U.S. stock futures edged higher early Tuesday ahead of key earnings and policy events.
24 February 2026
·······
Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl Capital shares dropped 4.2% in premarket trading Tuesday after Deutsche Bank downgraded the stock to Hold and cut its price target to $10. The move follows rising investor concern over private-credit fund liquidity and exposure to software loans. Blue Owl has lost over 16% in five days amid headlines on fund withdrawals and a disputed financing issue tied to CoreWeave. Investors are watching for the March 2 dividend payment.
24 February 2026
·
Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir shares fell 3.4% to $130.60 on Monday as investors sold off high-risk software stocks amid tariff uncertainty and renewed debate over AI disruption. U.S. stock indexes also declined, with software among the hardest hit. Traders are watching for Nvidia’s earnings report Wednesday, seen as the next major driver for AI-linked stocks. Futures edged higher early Tuesday, but markets remain volatile as tariff policy shifts.
24 February 2026
···
American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines shares fell 4.8% to $12.93 in premarket trading after a Northeast blizzard forced widespread flight cancellations. The company also filed a shelf registration late Monday, allowing for possible future sales of stock or debt. Operations resumed at Washington Reagan National and Philadelphia, with New York and Boston expected later Tuesday. Delta and United stocks also declined.
24 February 2026
···
Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk shares fell 2.5% to 245.1 Danish crowns Tuesday after its CagriSema obesity drug failed to match Eli Lilly’s tirzepatide in a Phase 3 trial. Barclays cut its peak sales forecast for CagriSema to $2 billion from $12 billion. Novo also reported mid-stage China trial results for its “triple G” obesity drug UBT251, showing up to 19.7% weight loss after 24 weeks.
24 February 2026
··
Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia shares traded at $191.55, up 0.9%, ahead of quarterly results due Wednesday after the bell. Options markets signal a possible 6% swing in either direction, reflecting investor focus on AI demand, supply constraints, and China sales. Wall Street expects revenue to jump over 68% to $66.16 billion. The company will release results at 4:20 p.m. ET, with a conference call at 5 p.m.
24 February 2026
····
Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio shares traded near $0.42 in early premarket Tuesday after plunging about 80% when its main drug failed to meet the primary goal in a Phase 3 trial. The company said the study’s key endpoint improved by 13.3 meters but did not reach statistical significance. Analysts downgraded the stock and flagged risks around funding and regulatory timelines. Gossamer plans to meet the FDA and paused another study.
24 February 2026
···
Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify shares fell 7.1% to $117.28 on Monday, their steepest drop in weeks, as investors sold off software stocks amid U.S. tariff uncertainty and AI disruption fears. The S&P 500 software group slid 4.3%. U.S. Customs set a 10% tariff rate starting Tuesday, with a possible increase to 15% under discussion. No new Shopify announcements were made Monday.
24 February 2026
···
1 … 10 11 12 13 14 … 594

Stock Market Today

  • Qualcomm Stock Hits 48% Year Gain, Analysts Question Valuation
    June 22, 2026, 11:46 PM EDT. Qualcomm (QCOM) stock closed at $221.90, up 28.3% year-to-date and 48% over the past year. Despite strong returns, its Discounted Cash Flow (DCF) analysis suggests the stock is overvalued by about 45.8%, with an intrinsic value estimate of $152.23 per share versus current price. The semiconductor company's recent gains come amid heightened demand discussions for chips and wireless tech. The P/E ratio and other valuation metrics are being scrutinized as investors debate whether current prices fully reflect future earnings potential. Qualcomm's 3-year and 5-year returns exceed 76%, but the valuation score stands at 3 out of 6, highlighting mixed signals on price justification amid market volatility.

Latest articles

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

Amazon Stock Just Got Hit Before Prime Day — AI Spending Fears Are Back

23 June 2026
Amazon shares plunged 4.75% to $232.79 as investors questioned whether the company’s massive AI and cloud spending will pay off quickly enough, just ahead of Prime Day—a key test of U.S. consumer demand—with Bank of America projecting $21.6 billion in sales for the event and analysts warning that profit quality could disappoint if shoppers focus on lower-margin essentials.
Keel Shares Hit Record—What’s Next for the Stock

Keel Shares Hit Record—What’s Next for the Stock

23 June 2026
Keel Infrastructure Corp. surged 5.9% to a 52-week high as investors bet its power sites can be converted to AI data-center leases, with shares ending at $6.66 on heavy volume; the stock’s rally now hinges on permits, construction, and landing customer contracts, while upcoming Russell 3000 index inclusion and recent $458 million convertible note financing add both opportunity and dilution risk.
Go toTop